BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang Z, Wang F, Li Z, Ye Z, Zhuo Q, Xu W, Liu W, Liu M, Fan G, Qin Y, Zhang Y, Chen X, Yu X, Xu X, Ji S. Value of lymphadenectomy in patients with surgically resected pancreatic neuroendocrine tumors. BMC Surg 2022;22:160. [PMID: 35538535 DOI: 10.1186/s12893-022-01595-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Sulciner ML, Clancy TE. Surgical Management of Pancreatic Neuroendocrine Tumors. Cancers 2023;15:2006. [DOI: 10.3390/cancers15072006] [Reference Citation Analysis]
2 Choi JH, Paik WH. Risk Stratification of Pancreatic Neuroendocrine Neoplasms Based on Clinical, Pathological, and Molecular Characteristics. J Clin Med 2022;11. [PMID: 36556070 DOI: 10.3390/jcm11247456] [Reference Citation Analysis]
3 Huang XT, Xie JZ, Huang CS, Li JH, Chen W, Liang LJ, Yin XY. Development and validation of nomogram to predict lymph node metastasis preoperatively in patients with pancreatic neuroendocrine tumor. HPB (Oxford) 2022;24:2112-8. [PMID: 36127226 DOI: 10.1016/j.hpb.2022.08.015] [Reference Citation Analysis]
4 Guo N, Liang Z, Xiong LJ. Clinicopathological characteristics, survival outcomes and prognostic factors in the cT1N0M0 pancreatic neuroendocrine tumors: A SEER-based study. Medicine (Baltimore) 2022;101:e31019. [PMID: 36254020 DOI: 10.1097/MD.0000000000031019] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]